BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 26549853)

  • 1. ATPergic signalling during seizures and epilepsy.
    Engel T; Alves M; Sheedy C; Henshall DC
    Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.
    Alves M; Gomez-Villafuertes R; Delanty N; Farrell MA; O'Brien DF; Miras-Portugal MT; Hernandez MD; Henshall DC; Engel T
    Epilepsia; 2017 Sep; 58(9):1603-1614. PubMed ID: 28733972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic receptors in embryonic and adult neurogenesis.
    Oliveira Á; Illes P; Ulrich H
    Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Seizures and Purinergic Signalling.
    Menéndez Méndez A; Smith J; Engel T
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2 receptor signaling in neurons and glial cells of the central nervous system.
    Köles L; Leichsenring A; Rubini P; Illes P
    Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy.
    Wong ZW; Engel T
    Neuropharmacology; 2023 Jan; 222():109303. PubMed ID: 36309046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.
    Alves M; Beamer E; Engel T
    Front Pharmacol; 2018; 9():193. PubMed ID: 29563872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.
    Engel T; Smith J; Alves M
    J Inflamm Res; 2021; 14():3367-3392. PubMed ID: 34305404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression of the Metabotropic P2Y Receptor Family in the Cortex Following Status Epilepticus and Neuroprotection
    Alves M; Smith J; Engel T
    Front Pharmacol; 2019; 10():1558. PubMed ID: 32009961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus.
    Henshall DC; Engel T
    Epilepsy Behav; 2015 Aug; 49():8-12. PubMed ID: 25843343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y
    Alves M; De Diego Garcia L; Conte G; Jimenez-Mateos EM; D'Orsi B; Sanz-Rodriguez A; Prehn JHM; Henshall DC; Engel T
    J Neurosci; 2019 Jul; 39(27):5377-5392. PubMed ID: 31048325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
    Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
    FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide signalling during inflammation.
    Idzko M; Ferrari D; Eltzschig HK
    Nature; 2014 May; 509(7500):310-7. PubMed ID: 24828189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: Evidence from purine biosensors and P2 receptor agonists and antagonists.
    Lopatář J; Dale N; Frenguelli BG
    Neuropharmacology; 2011; 61(1-2):25-34. PubMed ID: 21338615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
    Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
    Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing the Role of the P2X7 Receptor in Epilepsy.
    Alves M; de Diego-Garcia L; Engel T
    Methods Mol Biol; 2022; 2510():367-387. PubMed ID: 35776337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosinergic signaling in epilepsy.
    Boison D
    Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.